2 active not recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 2 |
Follow Abnormalities, Multiple: new trials by email Literature Review of Abnormalities, Multiple trials Research Report on Abnormalities, Multiple
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease (EMPA-PKD) Empagliflozin 10 MG, Placebo - Autosomal Dominant Polycystic Kidney | Phase 4 | Active not recruiting | Hannover Medical School | 44 | 2024-06-14 | 2025-11-24 |
| Statin Therapy in Patients With Early Stage ADPKD Pravastatin, Placebo - ADPKD, Autosomal Dominant Polycystic Kidney | Phase 4 | Active not recruiting | University of Colorado, Denver | 150 | 2017-08-31 | 2025-05-08 |
Polycystic Kidney, Autosomal Dominant (2)
Ciliopathies (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genetic Diseases, Inborn (2) · Kidney Diseases (2) · Kidney Diseases, Cystic (2) · Male Urogenital Diseases (2) · Polycystic Kidney Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2)
Pravastatin (1) · empagliflozin (1)
Hannover Medical School (1) · University of Colorado, Denver (1)
Germany (1) · United States (1)
PMID 39356039, PMID 38151173, PMID 39675824, PMID 40377984, PMID 41077128
2023 (1)